http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109342731-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94b3e3452cea93da522d25e041f55619 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c0118851c4c5eaf79c8403c86980e505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-533 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-533 |
| filingDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62d7cf9f71c35d08debdd38f0328f96c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64cd2485e36eadf3eff82fdb487af08e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8226b7ca759b53e32a21ee2842a04c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6caa9e73f4f8311d1c9449e59e758662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b98a4cb51008f6d4f3515f00ce940e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f0d9a4165d6cbe2304d08b953254240 |
| publicationDate | 2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109342731-A |
| titleOfInvention | Kit for simultaneous detection of gynecological tumor markers HER-2 and HE4 |
| abstract | The invention belongs to the technical field of immunoassays, and in particular relates to a kit for simultaneous detection of gynecological tumor markers HER-2 and HE4 and its application. The kit comprises: a tracer-labeled HER-2 antibody and a tracer-labeled HE4 antibody The above-mentioned tracer-labeled HER-2 antibody and tracer-labeled HE4 antibody can highly specifically bind to the gynecological tumor marker HER-2 or HE4 antigen, and then the kit can be used, using dual The labeled time-resolved fluorescence immunoassay method can simultaneously detect two tumor markers, human HER-2 and HE4, which facilitates the simultaneous analysis of breast, ovarian and endometrial cancers, thereby improving the efficiency of screening and clinical interpretation. Based on the kit, two results can be obtained in one operation, thus improving the testing efficiency, reducing errors caused by separate testing, and being beneficial to the screening and diagnosis of gynecological tumors. |
| priorityDate | 2018-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 561.